Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed From Small Lung Biopsies

Journal of Thoracic Oncology

English

P3.01-106 Real-World Data to Evaluate the Clinical Benefit of NGS for Directing Lung Adenocarcinoma Treatment

Journal of Thoracic Oncology

English

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Journal of Thoracic Oncology

English

Specialists to the Rescue of Oncologists for the Management of Toxicity Occurring Under Combination of Anticancer Therapies

Journal of Thoracic Oncology

English

P2.06-29 Expression of Estrogen Receptor Beta (ERb) and Its Prognostic Value in the Pleural Mesothelioma.

Journal of Thoracic Oncology

English

P1.04-13 Combining Clinical and Genomic Data for Predicting Response to Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.11-07 the Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project

Journal of Thoracic Oncology

English

OA10.02 Oncogene-Driven Patient Groups: A New Era for Research Partnerships

Journal of Thoracic Oncology

English

P066 a Phase I Study of Apatinib Combined With Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC

Journal of Thoracic Oncology

English

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P2.09-12 EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed From Small Lung Biopsies

P3.01-106 Real-World Data to Evaluate the Clinical Benefit of NGS for Directing Lung Adenocarcinoma Treatment

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Specialists to the Rescue of Oncologists for the Management of Toxicity Occurring Under Combination of Anticancer Therapies

P2.06-29 Expression of Estrogen Receptor Beta (ERb) and Its Prognostic Value in the Pleural Mesothelioma.

P1.04-13 Combining Clinical and Genomic Data for Predicting Response to Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

P3.11-07 the Quality of Screening: Comparing the Rush Lung Cancer Screening Program to the NLST and the VA Lung Cancer Screening Demonstration Project

OA10.02 Oncogene-Driven Patient Groups: A New Era for Research Partnerships

P066 a Phase I Study of Apatinib Combined With Pemetrexed and Carboplatin in Untreated EGFR-Negative Stage IV Non-Squamous NSCLC

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)